Susquehanna Portfolio Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.8M Buy
151,362
+113,777
+303% +$38.9M 0.87% 19
2026
Q1
$13.2M Hold
37,585
0.2% 137
2025
Q4
$12.3M Buy
+37,585
New +$11.9M 0.19% 144
2025
Q3
Sell
-2,100
Closed -$586K 1030
2025
Q2
$586K Buy
+2,100
New +$595K 0.01% 614
2024
Q3
Sell
-5,377
Closed -$1.68M 357
2024
Q2
$1.68M Sell
5,377
-131,854
-96% -$38.7M 0.07% 229
2024
Q1
$39M Sell
137,231
-6,991
-5% -$2.05M 0.91% 20
2023
Q4
$41.5M Buy
+144,222
New +$39.3M 0.74% 13

Other funds holding AMGN

Susquehanna Portfolio Strategies's AMGN Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Amgen (AMGN) stake by 303% in Q2 2026, buying an estimated $38.9M and bringing the position to 151,362 shares worth $54.8M. The position accounts for 0.87% of the portfolio, ranked #19.

Susquehanna Portfolio Strategies first reported a position in AMGN in Q4 2023 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Susquehanna Portfolio Strategies held 151,362 shares of Amgen worth $54.8M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 113,777 Amgen shares in Q2 2026, an estimated $38.9M.
  • Amgen made up 0.87% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #19 holding.
  • Susquehanna Portfolio Strategies first reported a position in Amgen in Q4 2023 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.